{
  "docId": "019de073-9cbe-768d-a7d1-8fc0965b655d",
  "docSlug": "4ccbe5a4f667a79f6253d55ec8458249",
  "documentTitle": "Absci | Investor Presentation Deck | 26 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 26,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Partnership Spotlight slide detailing specific deal terms with Merck and technical collaboration goals with NVIDIA.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9cbe-768d-a7d1-8fc0965b655d/22",
  "deckHref": "/decks/019de073-9cbe-768d-a7d1-8fc0965b655d",
  "deckJsonHref": "/decks/019de073-9cbe-768d-a7d1-8fc0965b655d.json",
  "deckAnchorHref": "/decks/019de073-9cbe-768d-a7d1-8fc0965b655d#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.55,
        "y": 0.25
      },
      "kind": "image",
      "text": "NVIDIA",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "29fa5832-fbbc-48ff-81e0-66a19692e323",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "image",
      "text": "Merck",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df9054cf-c455-4188-ad7f-4ce7e1e1a12a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "Drug discovery: Option to nominate up to 3 targets; $610M potential upfront + milestones; Tiered royalties; Research funding. Bionic enzymes: Generation of nsAA-containing custom bioproduction enzymes; Upfront and milestones.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b6c9a52-d7af-477d-bdeb-fba546aff195",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.55,
        "y": 0.45
      },
      "kind": "list",
      "text": "Absci and NVIDIA are collaborating to scale fully in silico Drug Creation platform. Early access to NVIDIA key technologies; Scale model training to NVIDIA SuperPOD; Dedicated expertise in optimizing Absci's AI compute.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9f7fec1-f7e0-4ca8-a1cd-cf16ff99475d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.9,
        "x": 0.05,
        "y": 0.11
      },
      "kind": "title",
      "text": "Absci collaborates with flagship partners to deliver better drugs to patients faster",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e8a883f-a5d2-4d71-9670-4cf27e2772ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}